- Home
- AORT vs WOOF Comparison
AORT vs WOOF Comparison
Compare AORT & WOOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AORT
- WOOF
- Stock Information
- Founded
- AORT 1984
- WOOF 1965
- Country
- AORT United States
- WOOF United States
- Employees
- AORT N/A
- WOOF N/A
- Industry
- AORT Medical/Dental Instruments
- WOOF Other Specialty Stores
- Sector
- AORT Health Care
- WOOF Consumer Discretionary
- Exchange
- AORT Nasdaq
- WOOF Nasdaq
- Market Cap
- AORT 1.4B
- WOOF N/A
- IPO Year
- AORT 1993
- WOOF 2021
- Fundamental
- Price
- AORT $31.66
- WOOF $2.97
- Analyst Decision
- AORT Strong Buy
- WOOF Buy
- Analyst Count
- AORT 5
- WOOF 8
- Target Price
- AORT $32.40
- WOOF $3.75
- AVG Volume (30 Days)
- AORT 349.3K
- WOOF 3.9M
- Earning Date
- AORT 08-07-2025
- WOOF 06-05-2025
- Dividend Yield
- AORT N/A
- WOOF N/A
- EPS Growth
- AORT N/A
- WOOF N/A
- EPS
- AORT N/A
- WOOF N/A
- Revenue
- AORT $390,084,000.00
- WOOF $6,080,721,000.00
- Revenue This Year
- AORT $12.18
- WOOF $0.04
- Revenue Next Year
- AORT $10.39
- WOOF $1.41
- P/E Ratio
- AORT N/A
- WOOF N/A
- Revenue Growth
- AORT 5.94
- WOOF N/A
- 52 Week Low
- AORT $21.97
- WOOF $2.23
- 52 Week High
- AORT $32.94
- WOOF $6.29
- Technical
- Relative Strength Index (RSI)
- AORT 62.03
- WOOF 50.41
- Support Level
- AORT $30.06
- WOOF $2.97
- Resistance Level
- AORT $32.94
- WOOF $3.16
- Average True Range (ATR)
- AORT 0.79
- WOOF 0.12
- MACD
- AORT 0.06
- WOOF 0.05
- Stochastic Oscillator
- AORT 61.37
- WOOF 68.85
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.